Mechanisms of Immune Checkpoint Resistance Mediated by LKB1 Tumor Suppressor in Lung Cancer

Aims to characterize mechanisms of immune evasion and resistance to immune checkpoint inhibition specific to the subset of lung cancer with loss of the LKB1 tumor suppressor, and to identify strategies to overcome this resistance.

Awarded By

  • DOD

Contributors

Amount

  • $100,000.00

Start/End

  • 2019 - 2020